OREXO US, INC.

Biopharma

NJ, USLatest filing Mar 4, 2026In-house team

Orexo US, Inc. is a biopharmaceutical company based in New Jersey that makes pharmaceuticals and health products. Its recent federal lobbying focused on issues related to alcohol and drug abuse, specifically advocacy on xylazine and solutions for adulterated-opioid overdoses and related federal funding, and on budget or appropriation matters. The company used the firm Steptoe LLP for this work.

Reported spend

Alcohol and Drug Abuse leads by disclosed activity

Filings

Most recent on Mar 4, 2026

Firms engaged

STEPTOE LLP leads by reported spend

AI Industry Profile

Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.

ApprovedSource: ai

Confidence

85%

Dominant share

100%

Industry count

Biopharma

100%

Client is explicitly described as a pharmaceuticals/health products company (Orexo US, Inc.) and is lobbying on opioid/xylazine overdose solutions — consistent with biopharma industry activity. Registered via an outside law firm does not change client industry.

Reported Spend Over Time

Annual totals based on disclosed filing amounts.

2026

$01 filings

What They're Lobbying On

Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.

Alcohol and Drug Abuse

ALC

1 mentions1 filingsLatest Mar 4, 2026

apportioned spend

Budget/Appropriations

BUD

1 mentions1 filingsLatest Mar 4, 2026

apportioned spend

Top Firms

The lobbying registrants handling this client, ranked by disclosed filing amounts.

STEPTOE LLP

Manufacturing

1 filingsLatest Mar 4, 2026

Law Firm.

Top Lobbyists

Lobbyists are ranked by appearances and an equal share of each filing's reported amount.

Recent Filings

The latest disclosures for this client.